Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
The same disparity between rich animal data and sparse human trials characterizes many peptide compounds, partly because the economics of pharmaceutical development disfavor compounds that cannot be patented in their natural form
Growth hormone fragments are prohibited at all times under S2 (peptide hormones, growth factors, related substances) on the WADA Prohibited List
If using monotherapy at 4.5 mg/week, vial counts roughly double from the 2.4 mg/week math above
Change the body, and the same milligrams land at a different occupancy and a different effect
US$ 26.87
US$ 28.02
US$ 20.12
